Products About Documents News Complaints Contacts
8 (800) 222-13-13 info@rkgroup.ru
NASH+ — Everolimus-eluting coronary stent
65 µm strutsUltra-thin 65 µm stent struts.
everolimus coatingThin 3 µm bioresorbable polymer coating with controlled drug release.
Nylon/Pebax balloonNominal 8 atm, rated burst 16 atm.
Pt-Ir markersTwo platinum-iridium radiopaque markers.
0.014″ guidewireCompatible with guidewires up to 0.014″ and 5F catheters.
  1. Home
  2. Products
  3. NASH+
Drug-eluting stent New

NASH+

Everolimus-eluting coronary stent

EverolimusCoating

Reg. cert. РЗН 2025/25736 dated 24.06.2025

Drag to rotate · schematic model

Description

NASH+ — Everolimus-eluting coronary stent

The NASH+ everolimus-eluting coronary stent is intended to increase the lumen diameter of the coronary vessels in patients with symptomatic coronary artery disease, including patients with acute myocardial infarction and patients with concomitant diabetes mellitus, caused by de novo focal lesions of the native coronary artery.

  • Ultra-thin struts (65 µm) reduce the risk of late stent thrombosis
  • Ultra-low crossing profile (~1.0 mm) for improved flexibility and deliverability
  • Increased radial strength gives reliable vessel-wall support and reduces recoil (<5%) for a stable result after implantation
  • A thin 3 µm bioresorbable polymer coating reduces the risk of vessel inflammation
  • The coating technology keeps the polymer intact after stent expansion and ensures controlled drug release

Contraindications apply. Read the instructions for use or consult a specialist.

Specifications

Drug coatingEverolimus
Nominal pressure (NP)8 atm
Rated burst pressure (RBP)16 atm
Guidewire compatibilitymax 0.014″
Catheter compatibility5F
Radiopaque markersPt-Ir, 2 pcs
Balloon materialNylon/Pebax
For hospitals and procurement

Russian stents,
direct from the factory

Availability, size range, tender documents and delivery terms — we reply within one working day.

Request a quote
8 (800) 222-13-13 info@rkgroup.ru Mon–Fri 9:00–18:00